Episode 150: EXXUA for depression, ubrogepant for migraine, PCI

Episode 150: EXXUA for depression, ubrogepant for migraine, PCI for stable angina, and a simple way to communications

Listen now

Description

This week, Gary, Kate, Henry and Mark discuss a newly approved medication for major depression in adults, initiation of abortive therapy using ubrogepant during migraine prodrome, the value of PCI for patients with stable angina, and a simple intervention to improve communication with hospitalized patients. And a quiz!

More Episodes

See all »

Episode 168: RSV med, colonoscopy by PCP, hair loss drug, and AI for ECGs

Published 11/18/24

Episode 167: laughter, HP eradication, antibiotics for delirium, and MRIs of the knee

Join Kate, Gary, Henry and Mark as they discuss a new therapy for dry eye syndrome, antibiotics for suspected UTI in adults with delirium, a new ACG guideline for treating H pylori, and the prevalence of knee pathology in asymptomatic adults. See below for links to the articles and other...

Published 11/06/24

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Join Gary, Kate, Mark and Henry as they discuss text messages for adolescent vaping cessation, stopping BP meds in nursing home residents with dementia, the benefits of SGLT-2 inhibitors, and mobile phone app–based artificial intelligence for diagnosing melanoma. Click here for transcript, notes...

Published 10/23/24